IMGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 5.07%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $45,624,932.36

ImmunoGen Insider Trading History Chart

ImmunoGen Share Price & Price History

^$31.23

+0.30 (1.20%)

As of 02/26/2024 01:00 AM ET

Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars

From GoldenCrest Metals | Ad

Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.

Learn More Now

ImmunoGen Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/16/2024	Theresa Wingrove	SVP	Sell	187,667	$29.64	$5,562,449.88	3,426
12/26/2023	Renee Lentini	VP	Sell	6,548	$29.74	$194,737.52	8,452
12/15/2023	Theresa Wingrove	SVP	Sell	117,445	$29.40	$3,452,883.00	2,811
11/30/2023	Kristine Peterson	Director	Sell	20,000	$28.90	$578,000.00
11/29/2023	Theresa Wingrove	SVP	Sell	6,792	$16.66	$113,154.72	2,811
11/17/2023	Stacy Ann Coen	SVP	Sell	78,223	$16.05	$1,255,479.15	36,966
11/15/2023	Theresa Wingrove	SVP	Sell	166,725	$15.85	$2,642,591.25	2,811
11/7/2023	Theresa Wingrove	SVP	Sell	19,517	$16.66	$325,153.22	2,811
11/6/2023	Renee Lentini	VP	Sell	219,545	$15.29	$3,356,843.05
10/16/2023	Theresa Wingrove	SVP	Sell	192,004	$14.40	$2,764,857.60	2,811
9/15/2023	Theresa Wingrove	SVP	Sell	192,013	$15.44	$2,964,680.72	2,811
8/9/2023	Stacy Ann Coen	SVP	Sell	100,210	$14.20	$1,422,982.00	10,960
8/4/2023	Stacy Ann Coen	SVP	Sell	80,326	$17.05	$1,369,558.30	10,960
8/3/2023	Mark J. Enyedy	CEO	Sell	1,020,000	$16.61	$16,942,200.00	441,449
8/2/2023	Renee Lentini	Insider	Sell	148,277	$17.55	$2,602,261.35	22,843
8/2/2023	Stacy Ann Coen	SVP	Sell	4,255	$18.12	$77,100.60	10,960

Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars

From GoldenCrest Metals | Ad

Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.

Learn More Now

SEC Filings (Institutional Ownership Changes) for ImmunoGen (NASDAQ:IMGN)

90.50% of ImmunoGen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ImmunoGen Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/29/2024	Kapitalo Investimentos Ltda	31,437	$0.93M	0.2%	N/A	0.012%
3/14/2024	Leo Wealth LLC	25,016	$0.74M	0.1%	N/A	0.009%
3/11/2024	Vanguard Group Inc.	25,466,950	$755.10M	0.0%	+4.0%	9.565%
3/5/2024	Wellington Management Group LLP	1,954,413	$57.95M	0.0%	-85.3%	0.734%
3/5/2024	Twin Focus Capital Partners LLC	31,875	$0.95M	0.1%	-50.1%	0.012%
3/1/2024	Goldman Sachs Group Inc.	1,189,485	$35.27M	0.0%	-4.0%	0.447%
2/28/2024	American International Group Inc.	119,145	$3.53M	0.0%	-0.4%	0.045%
2/23/2024	Chicago Partners Investment Group LLC	11,873	$0.35M	0.0%	N/A	0.004%
2/20/2024	Eventide Asset Management LLC	763,000	$22.62M	0.4%	-41.3%	0.287%
2/20/2024	Readystate Asset Management LP	149,510	$4.43M	0.1%	N/A	0.056%
2/17/2024	FIL Ltd	5,360,000	$158.92M	0.2%	N/A	2.013%
2/15/2024	Westchester Capital Management LLC	1,364,927	$40.47M	1.4%	N/A	0.513%
2/15/2024	Parkwood LLC	25,826	$0.77M	0.1%	N/A	0.010%
2/15/2024	HGC Investment Management Inc.	188,929	$5.60M	1.6%	N/A	0.071%
2/15/2024	Birchview Capital LP	188,000	$5.57M	4.4%	-1.1%	0.071%
2/15/2024	Bridgefront Capital LLC	11,509	$0.34M	0.3%	N/A	0.004%
2/14/2024	TIG Advisors LLC	2,313,670	$68.60M	8.6%	N/A	0.869%
2/14/2024	Twin Securities Inc.	221,622	$6.57M	6.9%	N/A	0.083%
2/14/2024	Avidity Partners Management LP	1,829,215	$54.24M	2.0%	-4.6%	0.687%
2/14/2024	PenderFund Capital Management Ltd.	27,580	$0.82M	0.0%	N/A	0.010%
2/14/2024	P Schoenfeld Asset Management LP	165,000	$4.89M	1.1%	N/A	0.062%
2/14/2024	Superstring Capital Management LP	598,072	$17.73M	12.7%	N/A	0.225%
2/14/2024	Avoro Capital Advisors LLC	875,000	$25.94M	0.4%	N/A	0.329%
2/14/2024	Angelo Gordon & CO. L.P.	80,000	$2.37M	0.8%	N/A	0.030%
2/14/2024	Kynam Capital Management LP	1,422,503	$42.18M	4.7%	N/A	0.534%
2/14/2024	Vazirani Asset Management LLC	200,000	$25K	0.1%	N/A	0.075%
2/14/2024	Harvest Management LLC	214,000	$6.35M	5.9%	N/A	0.080%
2/14/2024	Capital Fund Management S.A.	297,985	$8.84M	0.0%	+364.6%	0.112%
2/14/2024	Water Island Capital LLC	893,758	$26.50M	2.7%	N/A	0.336%
2/14/2024	Sectoral Asset Management Inc.	17,896	$0.53M	0.2%	-96.1%	0.007%
2/14/2024	Bardin Hill Management Partners LP	40,806	$1.21M	0.5%	N/A	0.015%
2/13/2024	GABELLI & Co INVESTMENT ADVISERS INC.	624,750	$18.52M	3.5%	N/A	0.235%
2/13/2024	Gabelli Funds LLC	745,500	$22.10M	0.2%	N/A	0.280%
2/13/2024	DCF Advisers LLC	14,000	$0.42M	0.2%	+8.9%	0.005%
2/13/2024	Armistice Capital LLC	134,698	$3.99M	0.1%	N/A	0.051%
2/13/2024	Affinity Asset Advisors LLC	1,404,608	$41.65M	7.7%	N/A	0.528%
2/13/2024	KRYGER CAPITAL Ltd	2,036,155	$60.37M	9.6%	N/A	0.765%
2/13/2024	Carmignac Gestion	114,380	$3.39M	0.1%	N/A	0.043%
2/13/2024	Rafferty Asset Management LLC	307,369	$9.11M	0.0%	-45.8%	0.115%
2/13/2024	NEOS Investment Management LLC	17,626	$0.52M	0.0%	N/A	0.007%
2/13/2024	KBC Group NV	4,734	$0.14M	0.0%	N/A	0.002%
2/13/2024	California State Teachers Retirement System	250,499	$7.43M	0.0%	+1.7%	0.094%
2/12/2024	Scotia Capital Inc.	19,110	$0.57M	0.0%	+27.6%	0.007%
2/12/2024	Highbridge Capital Management LLC	200,000	$5.93M	0.2%	N/A	0.075%
2/12/2024	Olympiad Research LP	67,137	$1.99M	1.6%	N/A	0.025%
2/12/2024	Decheng Capital LLC	659,928	$19.57M	5.5%	N/A	0.248%
2/12/2024	Allianz Asset Management GmbH	214,350	$6.36M	0.0%	+380.6%	0.081%
2/12/2024	Parallel Advisors LLC	876	$26K	0.0%	+3,028.6%	0.000%
2/12/2024	Artisan Partners Limited Partnership	1,172,323	$34.76M	0.1%	-68.5%	0.440%
2/12/2024	Hsbc Holdings PLC	519,779	$15.44M	0.0%	N/A	0.195%
2/9/2024	Assetmark Inc.	3,880	$0.12M	0.0%	+45.3%	0.001%
2/9/2024	BI Asset Management Fondsmaeglerselskab A S	35,409	$1.05M	0.0%	-55.0%	0.013%
2/9/2024	Dynamic Technology Lab Private Ltd	72,466	$2.15M	0.2%	N/A	0.027%
2/9/2024	Norges Bank	5,539,334	$164.24M	0.0%	N/A	2.080%
2/8/2024	Longfellow Investment Management Co. LLC	2,268	$67K	0.0%	N/A	0.001%
2/8/2024	Panagora Asset Management Inc.	409,658	$12.15M	0.1%	-62.7%	0.154%
2/8/2024	Vanguard Personalized Indexing Management LLC	7,829	$0.23M	0.0%	N/A	0.003%
2/8/2024	Nicholas Investment Partners LP	148,672	$4.41M	0.5%	-92.8%	0.056%
2/7/2024	Principal Financial Group Inc.	1,127,402	$33.43M	0.0%	+14.5%	0.423%
2/7/2024	USA Financial Formulas	3,893	$0.12M	0.0%	N/A	0.001%
2/7/2024	BNP Paribas Financial Markets	137,098	$4.07M	0.0%	-41.9%	0.051%
2/7/2024	Teacher Retirement System of Texas	54,685	$1.62M	0.0%	-12.0%	0.021%
2/7/2024	Versor Investments LP	192,295	$5.70M	1.2%	N/A	0.072%
2/7/2024	Alpine Associates Management Inc.	1,761,300	$52.22M	2.7%	N/A	0.661%
2/7/2024	Kellner Capital LLC	69,200	$2.05M	3.7%	N/A	0.026%
2/7/2024	E Fund Management Co. Ltd.	16,443	$0.49M	0.0%	-43.5%	0.006%
2/7/2024	Segantii Capital Management Ltd	415,000	$12.31M	0.6%	N/A	0.156%
2/6/2024	Charles Schwab Investment Management Inc.	1,892,446	$56.11M	0.0%	+3.4%	0.711%
2/6/2024	BCK Capital Management LP	35,000	$1.04M	1.0%	N/A	0.013%
2/6/2024	MeadowBrook Investment Advisors LLC	1,800	$53K	0.1%	N/A	0.001%
2/6/2024	Amalgamated Bank	29,087	$0.86M	0.0%	-6.4%	0.011%
2/6/2024	Los Angeles Capital Management LLC	42,170	$1.25M	0.0%	-10.2%	0.016%
2/6/2024	Natixis Advisors L.P.	43,254	$1.28M	0.0%	+3.3%	0.016%
2/6/2024	New York Life Investment Management LLC	682,396	$20.23M	0.2%	N/A	0.256%
2/5/2024	Victory Capital Management Inc.	35,213	$1.04M	0.0%	-75.0%	0.013%
2/5/2024	Fernwood Investment Management LLC	83,780	$2.48M	0.6%	-2.9%	0.031%
2/5/2024	Russell Investments Group Ltd.	15,134	$0.45M	0.0%	-14.0%	0.006%
2/1/2024	Wolverine Asset Management LLC	93,223	$2.76M	0.0%	N/A	0.035%
2/1/2024	New York State Common Retirement Fund	146,489	$4.34M	0.0%	-54.9%	0.055%
2/1/2024	Handelsbanken Fonder AB	48,700	$1.44M	0.0%	+10.4%	0.018%
1/31/2024	Calamos Advisors LLC	191,117	$5.67M	0.0%	N/A	0.072%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	50,066	$1.48M	0.0%	+12.0%	0.019%
1/30/2024	Mackenzie Financial Corp	14,265	$0.42M	0.0%	-20.1%	0.005%
1/30/2024	Strs Ohio	47,000	$1.39M	0.0%	+62.1%	0.018%
1/29/2024	Baystate Wealth Management LLC	24,106	$0.72M	0.1%	N/A	0.009%
1/29/2024	Friedenthal Financial	23,440	$0.70M	0.5%	N/A	0.009%
1/25/2024	TFC Financial Management Inc.	10,800	$0.32M	0.1%	-39.8%	0.004%
1/25/2024	Nisa Investment Advisors LLC	6,970	$0.21M	0.0%	+8.4%	0.003%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	127,205	$3.77M	0.0%	-5.2%	0.048%
1/24/2024	DekaBank Deutsche Girozentrale	72,697	$2.15M	0.0%	+4.0%	0.027%
1/24/2024	Arizona State Retirement System	66,111	$1.96M	0.0%	+6.2%	0.025%
1/24/2024	China Universal Asset Management Co. Ltd.	30,961	$0.92M	0.2%	+384.9%	0.012%
1/22/2024	Perkins Capital Management Inc.	10,400	$0.31M	0.3%	-14.0%	0.004%
1/19/2024	Kercheville Advisors LLC	114,897	$3.41M	1.9%	-1.4%	0.043%
1/19/2024	Pinnacle Associates Ltd.	1,011,792	$30M	0.5%	-0.4%	0.380%
1/18/2024	McGlone Suttner Wealth Management Inc.	1,558	$46K	0.0%	N/A	0.001%
1/16/2024	Raymond James Financial Services Advisors Inc.	28,191	$0.84M	0.0%	-9.3%	0.011%
1/16/2024	Raymond James & Associates	104,485	$3.10M	0.0%	-37.6%	0.039%
1/12/2024	SG Americas Securities LLC	128,745	$3.82M	0.0%	+45.9%	0.048%
1/12/2024	First Bank & Trust	19,374	$0.57M	0.1%	N/A	0.007%

Data available starting January 2016

ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian cancer; and a cell-surface protein expressed in various epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers, as well as Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti-FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts. As of February 12, 2024, ImmunoGen, Inc. operates as a subsidiary of AbbVie Inc.

Today's Range

Now: $31.23

$31.23

50 Day Range

MA: $31.23

$31.23

52 Week Range

Now: $31.23

$3.61

$31.25

Volume

40 shs

Average Volume

8,778,325 shs

Market Capitalization

$8.32 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Who are the company insiders with the largest holdings of ImmunoGen?: ImmunoGen's top insider shareholders include:
Mark J Enyedy (CEO)
Stacy Ann Coen (SVP)
Renee Lentini (Insider)
Renee Lentini (VP)
Theresa Wingrove (SVP)
Kristine Peterson (Director)
Learn More about top insider investors at ImmunoGen.